Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. (GMTX) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
gmtx · market cap & enterprise value · FMP · as of Dec 30, 2022
Core market cap & key metrics
As of Dec 30, 2022, Gemini Therapeutics, Inc. (GMTX) has a market cap — also referred to as its net worth or valuation — of $25,491,780, making it one of the top most valuable companies globally. Market Cap = $1.35 × shares outstanding.
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Gemini Therapeutics, Inc. (GMTX) has a market cap — also referred to as its net worth or valuation — of $25,491,780 as of Dec 30, 2022, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Gemini Therapeutics, Inc. reached its all-time high market cap of $0 on —. Comparing the Gemini Therapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Gemini Therapeutics, Inc. net worth vs peers and ask how Gemini Therapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
GMTX market cap · 6 questionsGemini Therapeutics, Inc.'s net worth — measured as market capitalization — is $25,491,780 as of Dec 30, 2022. It ranks #0 globally. Market Cap = $$1.35 (price) × shares outstanding.